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ABSTRACT 
Glaucoma, a common cause of optic neuropathy, is associated with elevated 
intraocular pressure (IOP) and is the leading cause of irreversible visual disability. 
Steroid-induced glaucoma, a common type of secondary glaucoma, is also associated 
with elevated IOP (steroid-induced ocular hypertension (SIOH)). SIOH and glaucoma 
are currently treated with antiglaucoma agents, which often have suboptimal efficacy 
and are associated with adverse effects. The objective of this study was to determine if 
topical application of /nms-resveratrol reduces IOP in rats with SIOH and to 
investigate its mechanisms of action. This study was divided into in vivo and in vitro 
studies. In the in vivo study, we evaluated the oculohypotensive effects of topical 
toms-resveratrol in normal and SIOH rats and investigated the role of adenosine 
receptors (ARs) and transforming growth factor-P (TGF-p) signalling in the IOP 
lowering effect of fnms-resveratrol. Involvement of AR was studied by observing the 
IOP changes in response to /rara-resveratrol after pre-treating SIOH animals with AR 
subtype-specific antagonists. The study also investigated phospholipase C (PLC) 
activation, extracellular regulated kinase 1/2 (ERK1/2) phosphorylation and increased 
matrix metalloproteinases (MMPs) secretion in the aqueous humour (AH) as 
mechanism of resveratrol-induced oculohypotension in SIOH rats. In vitro studies 
evaluated the effect of frans-resveratrol on cellular signalling pathways of ARs and 
TGF-p in primary human trabecular meshwork cells (HTMCs). Single drop of all 
concentrations of toms-resveratrol produced significant oculohypotension in 
normotensive rats and 0.2% concentration produced maximum IOP reduction. Twice-
daily topical application of fnms-resveratrol 0.2% for 21-day in SIOH rats resulted in 
significant and sustained IOP reduction. This was associated with significantly higher 
AH MMP-2 level; significantly reduced trabecular meshwork (TM) thickness and 
increased number of TM cells. Treatment with /raws-resveratrol also significantly 
increased the ganglion cell survival and reduced retinal oxidative stress. Pretreatment 
with adenosine Ai receptor antagonist inhibited the oculohypotensive effect of 
resveratrol. The use of Ai AR, PLC and ERK 1/2 inhibitors also reduced resveratrol-
induced MMP-2 secretion. These results were further supported by in vitro study that 
demonstrated that ERK1/2, PLC and MMP-2 secretion by HTMC is stimulated after 
resveratrol treatment and these effects are associated with upregulation of Ai AR gene 
expression. Topical /r<ms-resveratrol also produced significantly raised plasminogen 
activator levels and combined TGF-p2+resveratrol treatment caused significant 
upregulation of inhibitory SMAD7 when compared to TGF-P2-only treated group. 
Hence, it could be concluded that frvms-resveratrol-induced oculohypotension in 
SIOH rats involves its agonistic activity at the AiAR leading to PLC activation, ERK 
1/2 phosphorylation and increased MMP-2 secretion. Increased MMP-2 secretion 
seems to cause changes in TM favourable for AH outflow leading to reduced IOP. 
7><ms-resveratrol-induced oculohypotension could also be attributed to increased level 
of plasminogen activators, which seems to result from increased expression of 
inhibitory SMAD7, a TGF-p2 signalling molecule. Although current study, for the 
first time, has clearly demonstrated the significant effects of topical fratts-resveratrol 
on IOP in rats with SIOH and some of the underlying mechanisms; further 
investigations are needed to fully understand the mechanisms of action of trans-
resveratrol and to explore its potential as a future antiglaucoma agent. 
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